Trial Profile
Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 30 Nov 2015 New trial record